Protein kinase Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) promotes obesity-induced hyperinsulinemia Academic Article uri icon

Overview

MeSH Major

  • Insulin
  • Insulin Resistance
  • Insulin-Secreting Cells
  • Obesity
  • Protein-Serine-Threonine Kinases

abstract

  • Previous studies revealed a paradox whereby mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4) acted as a negative regulator of insulin sensitivity in chronically obese mice, yet systemic deletion of Map4k4 did not improve glucose tolerance. Here, we report markedly reduced glucose-responsive plasma insulin and C-peptide levels in whole body Map4k4-depleted mice (M4K4 iKO) as well as an impaired first phase of insulin secretion from islets derived from M4K4 iKO mice ex vivo After long-term high fat diet (HFD), M4K4 iKO mice pancreata also displayed reduced β cell mass, fewer proliferating β cells and reduced islet-specific gene mRNA expression compared with controls, although insulin content was normal. Interestingly, the reduced plasma insulin in M4K4 iKO mice exposed to chronic (16 weeks) HFD was not observed in response to acute HFD challenge or short term treatment with the insulin receptor antagonist S961. Furthermore, the improved insulin sensitivity in obese M4K4 iKO mice was abrogated by high exogenous insulin over the course of a euglycemic clamp study, indicating that hypoinsulinemia promotes insulin sensitivity in chronically obese M4K4 iKO mice. These results demonstrate that protein kinase Map4k4 drives obesity-induced hyperinsulinemia and insulin resistance in part by promoting insulin secretion from β cells in mice.

publication date

  • July 29, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4965570

Digital Object Identifier (DOI)

  • 10.1074/jbc.M116.718932

PubMed ID

  • 27226575

Additional Document Info

start page

  • 16221

end page

  • 30

volume

  • 291

number

  • 31